Suchergebnisse - "Pinato, David J"

PubPharm (9)

1

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

2

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Liver Int. 2022 Nov;42(11):2352-2353. - PMID 36162086

3

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

4

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

enthalten in: Journal of hepatology | 2022

von Scheiner, B. | Pomej, K. | Kirstein, M. | +38

CommentIn: J Hepatol. 2022 Apr;76(4):987-988. - PMID 34780876

5

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Buti, S. | Bersanelli, M. | Perrone, F. | +58

CommentIn: Eur J Cancer. 2021 Sep;155:313-314. - PMID 34373189

6

Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cortellini, A. | Cannita, K. | Tiseo, M. | +49

CommentIn: Eur J Cancer. 2021 Sep;155:294-295. - PMID 34364743

7

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy

enthalten in: Journal for immunotherapy of cancer | 2021

von Cortellini, A. | Di Maio, M. | Nigro, O. | +58

8

Shifting paradigms in the systemic management of hepatocellular carcinoma

enthalten in: The lancet. Gastroenterology & hepatology | 2020

von Pinato, D.

9

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer : A Retrospective Study

enthalten in: The Journal of urology | 2020

von Miller, N. | Khaki, A. | Diamantopoulos, L. | +32

CommentIn: J Urol. 2020 Jul;204(1):69-70. - PMID 32314930

1
[1]